reported an NRAS mutation in cutaneous RDD (47), indicating that NRAS mutations in the MAPK/ERK pathway may be involved in the pathogenesis of cutaneous RDD. This evidence concerns the gene NRAS and sinus histiocytosis with massive lymphadenopathy.